CHC(消費者保健)市場年鑑:2023年
市場調查報告書
商品編碼
1182424

CHC(消費者保健)市場年鑑:2023年

CHC YearBook 2023

出版日期: | 出版商: Nicholas Hall Group of Companies | 英文 304 Pages | 訂單完成後即時交付

價格
簡介目錄

本報告提供全球CHC(消費者保健)市場相關調查,消費者保健品領域趨勢各地區趨勢,主要加入企業和領導品牌,新產品開發趨勢等相關資訊。

樣本圖


目錄

CHC市場定義

第1章 全球市場的檢討

  • 全球概要
  • 競爭情形
  • 交換器
  • 品牌和革新
  • 零售
  • 預測

第2章 各地區檢討

  • 北美
  • 東、東南亞
  • 西歐
  • 中歐、東歐
  • 日本
  • 南美
  • 印度半島
  • 澳洲

第3章 主要市場

  • 美國
  • 中國
  • 日本
  • 俄羅斯
  • 德國
  • 法國
  • 巴西
  • 義大利
  • 印度
  • 英國
  • 波蘭
  • 墨西哥
  • 澳洲
  • 加拿大
  • 韓國

第4章 各類別檢討

  • 止痛藥
  • 咳嗽、感冒、過敏
  • 消化器官
  • 維他命,礦物,補充品
  • 皮膚科
  • 生活方式CHC

第5章 主要企業

  • Haleon
  • J&J
  • Bayer
  • Sanofi
  • Reckitt
  • P&G
  • Taisho
  • China Resources 999
  • Nestle
  • Stada
  • Otsuka
  • Abbott
  • Prestige Consumer Healthcare
  • Teva
  • Bausch Health
  • Viatris
  • Perrigo
  • Mondelez
  • Church & Dwight
  • Hypera Pharma

第6章 合併和收購

第7章 領導品牌

第8章 熱門話題

第9章 Rx-to-OTC交換器

  • 概要
  • 西歐
  • 北美
  • 日本
  • 澳洲
  • 新興市場
  • 大規模交換器

第10章 新產品的開發與革新

  • 止痛藥
  • 咳嗽、感冒、過敏
  • 消化器官
  • 維他命,礦物,補充品
  • 皮膚科
  • 生活方式CHC

第11章 全球零售業

第12章 公司所有權

第13章 品牌和市場行銷

第14章 製造商協會

第15章 詞彙表

簡介目錄

“CHC YearBook 2023” gives you the most up-to-date and fully-informed picture of the CHC industry around the world, featuring expert analysis and incorporating full year-end 2022 data from the only dedicated worldwide CHC database, Nicholas Hall's unique and invaluable DB6 Global CHC Database.

SAMPLE VIEW


CHC FACTS & FIGURES IN FOCUS

A vital resource for Consumer Health marketers, offering instant access to the key facts & figures needed to support quick and accurate decision-making, including full year-end 2022 sales data from the only dedicated worldwide CHC sales database.

Expanded coverage

“CHC YearBook 2023” includes:

All channels data for the total CHC market, including splits for Store, Direct and Internet & mail order sales. Selected chapters feature added detail of sales via Direct (MLM) and Internet & mail order channels, reflecting the latest information from our dedicated DB6 database.

“CHC YearBook” is used by top OTC, pharma and consumer health companies, investment banks and consultants around the world.

Depending on your requirements, the report is available in various digital licences (Site or Global) or as individual print copies.

With extensive knowledge and experience in benchmarking the world of consumer health, Nicholas Hall's “CHC YearBook 2023” provides a focused set of data and analysis. Find all the facts, all the figures, at your fingertips.

Global Review

  • Highlighting major developments and global trends, and forecasting the CHC outlook for the future

Regional Review

  • 8 major regions come under the spotlight, with the focus on key markets, trends and developments

Leading Markets

  • Coverage of the Top 15 markets includes topline data by category, leading marketers and brands - PLUS a country-by-country review of regulations, switch environment, advertising and distribution

Category Review

  • Global coverage of Analgesics, CCA, Gastrointestinals, VMS, Derma and Lifestyle CHC

Leading Companies

  • Profiles of the Top 20 CHC players across the world.
  • Leading 250 CHC marketers by sales with CAGR 2018-22

Mergers & Acquisitions

  • All the major M&A activity, joint-ventures and alliances since 2018 - PLUS coverage of multiples paid for acquisitions in the CHC industry

Leading Brands

  • The leading 250 CHC brands by sales - PLUS concise profiles of the Top 25 brands

Hot Topics

  • Analysis of the latest hot-button issues affecting consumer health

Rx-to-OTC Switch

  • Overview of the switch environment in key markets - PLUS profiles of significant Rx-to-OTC switches

New Product Development & Innovation

  • Overview of latest activity in delivery formats and NPD across CHC categories

Global Retailing

  • Comprehensive overview of the fast-changing global retailing environment - PLUS major retailer profiles

Essential Reference Tables

  • Information on classification of ingredients, company ownership, brands & marketers and manufacturers' associations - PLUS a CHC glossary

Table of Contents

CHC Market Definition

1. Global Review

  • World Overview
  • Competitive Landscape
  • Switch
  • Brands & Innovation
  • Retailing
  • Outlook

2. Regional Review

  • North America
  • East & South East Asia
  • Western Europe
  • Central & Eastern Europe
  • Japan
  • Latin America
  • Indian Subcontinent
  • Australasia

3. Leading Markets

  • USA
  • China
  • Japan
  • Russia
  • Germany
  • France
  • Brazil
  • Italy
  • India
  • UK
  • Poland
  • Mexico
  • Australia
  • Canada
  • South Korea

4. Category Review

  • Analgesics
  • Cough, cold & allergy
  • Gastrointestinals
  • Vitamins, minerals & supplements
  • Dermatologicals
  • Lifestyle CHC

5. Leading Companies

  • Haleon
  • J&J
  • Bayer
  • Sanofi
  • Reckitt
  • P&G
  • Taisho
  • China Resources 999
  • Nestlé
  • Stada
  • Otsuka
  • Abbott
  • Prestige Consumer Healthcare
  • Teva
  • Bausch Health
  • Viatris
  • Perrigo
  • Mondelez
  • Church & Dwight
  • Hypera Pharma

6. Mergers & Acquisitions

7. Leading Brands

  • Vicks
  • Tylenol
  • Mucinex
  • Advil
  • Nature Made
  • Voltaren
  • Centrum
  • Panadol
  • Halls
  • Nicorette
  • Dong-e E-Jiao
  • Nature's Bounty
  • Zyrtec
  • Strepsils
  • Nurofen
  • Claritin
  • Doliprane
  • Olly
  • Allegra
  • 999 Gan Mao Ling
  • Caltrate
  • Bayer Aspirin
  • Yunnan Baiyao
  • Fupai E-Jiao
  • Ricola

8. Hot Topics

  • Growing demand for devices and e-Health provides new opportunities to consumerise health services
  • Consumers' relationship with and access to brands is changing in the digital age
  • Personalisation still a notable trend in consumer health NPD
  • Sustainability & transparency remain targets for investment in CHC

9. Rx-to-OTC Switch

  • Overview
  • Western Europe
  • North America
  • Japan
  • Australasia
  • Emerging markets
  • The Big Switches
    • Allegra
    • Alli, Xenical
    • Differin
    • ellaOne
    • Flonase / Flixonase
    • Formigran
    • Hana, Lovima
    • Loxonin S
    • Maloff Protect
    • MiraLAX
    • Mucinex
    • Nasacort
    • Nexium 24HR
    • Plan B, NorLevo, Postinor, Levonelle
    • Prevacid 24HR
    • Rhinocort
    • Silvasta, MaxOn Active / Tadalafil MaxOn, Viagra Connect, Cialis
    • Volini
    • Voltaren
    • Xyzal
    • Zyrtec

10. New Product Development & Innovation

  • Analgesics
  • Cough, cold & allergy
  • Gastrointestinals
  • Vitamins, minerals & supplements
  • Dermatologicals
  • Lifestyle CHC

11. Global Retailing

12. Company Ownership

13. Brands & Marketers

14. Manufacturers' Associations

15. Glossary

Charts

  • Chart 1: Global CHC sales by region 2022
  • Chart 2: Global CHC sales by category 2022
  • Chart 3: Global CHC forecasts by region
  • Chart 4: Global CHC forecasts by category
  • Chart 5: North America CHC market by category 2022
  • Chart 6: North America leading CHC marketers & brands 2022
  • Chart 7: E&SE Asia CHC market by category 2022
  • Chart 8: E&SE Asia leading CHC marketers & brands 2022
  • Chart 9: Western Europe CHC market by category 2022
  • Chart 10: Western Europe leading CHC marketers & brands 2022
  • Chart 11: C&E Europe CHC market by category 2022
  • Chart 12: C&E Europe leading CHC marketers & brands 2022
  • Chart 13: Japan CHC market by category 2022
  • Chart 14: Japan leading CHC marketers & brands 2022
  • Chart 15: Latin America CHC market by category 2022
  • Chart 16: Latin America leading CHC marketers & brands 2022
  • Chart 17: Indian Subcontinent CHC market by category 2022
  • Chart 18: Indian Subcontinent leading CHC marketers & brands 2022
  • Chart 19: Australasia CHC market by category 2022
  • Chart 20: Australasia leading CHC marketers & brands 2022
  • Chart 21: Global leading 15 CHC markets 2022
  • Chart 22: USA CHC market by category 2022
  • Chart 23: USA leading CHC marketers & brands 2022
  • Chart 24: China CHC market by category 2022
  • Chart 25: China leading CHC marketers & brands 2022
  • Chart 26: Japan CHC market by category 2022
  • Chart 27: Japan leading CHC marketers & brands 2022
  • Chart 28: Russia CHC market by category 2022
  • Chart 29: Russia leading CHC marketers & brands 2022
  • Chart 30: Germany CHC market by category 2022
  • Chart 31: Germany leading CHC marketers & brands 2022
  • Chart 32: France CHC market by category 2022
  • Chart 33: France leading CHC marketers & brands 2022
  • Chart 34: Brazil CHC market by category 2022
  • Chart 35: Brazil leading CHC marketers & brands 2022
  • Chart 36: Italy CHC market by category 2022
  • Chart 37: Italy leading CHC marketers & brands 2022
  • Chart 38: India CHC market by category 2022
  • Chart 39: India leading CHC marketers & brands 2022
  • Chart 40: UK CHC market by category 2022
  • Chart 41: UK leading CHC marketers & brands 2022
  • Chart 42: Poland CHC market by category 2022
  • Chart 43: Poland leading CHC marketers & brands 2022
  • Chart 44: Mexico CHC market by category 2022
  • Chart 45: Mexico leading CHC marketers & brands 2022
  • Chart 46: Australia CHC market by category 2022
  • Chart 47: Australia leading CHC marketers & brands 2022
  • Chart 48: Canada CHC market by category 2022
  • Chart 49: Canada leading CHC marketers & brands 2022
  • Chart 50: South Korea CHC market by category 2022
  • Chart 51: South Korea leading CHC marketers & brands 2022
  • Chart 52: Global CHC analgesics category split 2022
  • Chart 53: Leading analgesic brands 2022
  • Chart 54: Global CHC CCA category split 2022
  • Chart 55: Leading CCA brands 2022
  • Chart 56: Global CHC GIs category split 2022
  • Chart 57: Leading GI brands 2022
  • Chart 58: Global CHC VMS category split 2022
  • Chart 59: Leading VMS brands 2022
  • Chart 60: Global CHC dermatologicals category split 2022
  • Chart 61: Leading dermatological brands 2022
  • Chart 62: Global lifestyle CHC category split 2022
  • Chart 63: Leading lifestyle CHC brands 2022
  • Chart 64: Top 250 CHC marketers 2022
  • Chart 65: CHC merger, acquisition, alliance & joint-venture activity 2018-2023
  • Chart 66: Multiples paid for CHC acquisitions 2018-2022
  • Chart 67: Leading CHC brands 2022
  • Chart 68: Legal status of ingredients in selected world markets
  • Chart 69: Legal status of ingredients in selected European markets (I)
  • Chart 70: Legal status of ingredients in selected European markets (II)
  • Chart 71: Big Switches global CHC sales 2022
  • Chart 72: Company Ownership Index
  • Chart 73: Brands & Marketers Index